Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CD PRIVATE EQUITY FUND III Fund Information / Factsheet 2018

Jan 11, 2018

64628_rns_2018-01-11_5b3b8809-3808-4bbe-b2ee-b850b942ab66.pdf

Fund Information / Factsheet

Open in viewer

Opens in your device viewer

12 January 2018

==> picture [164 x 52] intentionally omitted <==

Cordish Dixon Private Equity Fund III (Fund)

ASX: CD3

NTA & Fund Update – 31 December 2017

NTA update

The estimated unaudited net tangible asset value before withholding tax on unpaid distributions at 31 December 2017 was $1.48* per unit (30 November 2017 was $1.52* per unit).

Fund update

Capital commitment

At 31 December 2017, US Select Private Opportunities Fund III L.P. ( LP ). has called US$38.5 million (or 33.8% of capital committed). The Fund’s proportionate share is approximately US$27.4 million (a 71.2% share).

New commitment

In December, the LP committed US$10 million to Bertram Growth Capital III, L.P. (Bertram), and US$5 million to Telescope Partners I, L.P. (Telescope). Bertram is a private equity firm targeting investments in lower middle market companies. Telescope is an active growth equity firm partnering with best in class entrepreneurs across the technology landscape.

Drawdowns

During the month, the LP received drawdown requests from Bertram Growth Capital III, L.P., NMS Fund III, L.P. and DFW Capital Partners V, L.P. for a total consideration of US$3.9 million.

At 31 December 2017, net drawdown requests received from underlying investments were approximately US$29.2 million (or 23.9% of total fund committed by the LP).

For further information, contact:

Alex MacLachlan 1300 454 801

*Source: Walsh & Company Investments Limited – the historical performance is not a guarantee of the future performance of the Fund.

Level 15, 100 Pacific Highway North Sydney NSW 2060 cordishdixonfunds.com.au T 1300 883 158 F 1300 883 159 E [email protected] ARSN 612 132 813